English
Français
Deutsch
Italiano
Português
Русский
Español
简体中文
हिन्दी
日本語
By Josh Beckerman
Bio-Path Holdings shares fell 18% to $1.74 Monday after Friday’s announcement of a stock and warrant offering.
On Friday, its shares rose 9%, marking the fourth consecutive day of increases.
The oncology-focused biotechnology company didn’t list the expected size of the offering. Bio-Path intends to use proceeds for working capital and general corporate purposes.
Write to Josh Beckerman at [email protected]
Read the full article here